{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T14:47:43Z","timestamp":1767970063269,"version":"3.49.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2012,3,2]],"date-time":"2012-03-02T00:00:00Z","timestamp":1330646400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1007\/s00417-012-1970-3","type":"journal-article","created":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T08:00:08Z","timestamp":1330588808000},"page":"1467-1476","source":"Crossref","is-referenced-by-count":12,"title":["EXTEND III: Efficacy and safety of ranibizumab in South Korean and Taiwanese patients with subfoveal CNV secondary to AMD"],"prefix":"10.1007","volume":"250","author":[{"name":"on behalf of the EXTEND III study group","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oh-Woong","family":"Kwon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fenq Lih","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hum","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi-Chun","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shwu-Jiuan","family":"Sheu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young-Hee","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,3,2]]},"reference":[{"key":"1970_CR1","unstructured":"WHO. Magnitude and causes of visual impairment [fact sheet no. 282]. Geneva: World Health Organization. URL http:\/\/www.who.int\/mediacentre\/factsheets\/fs282\/en\/ . Accessed on August 01, 2011"},{"key":"1970_CR2","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1136\/bjo.2006.098426","volume":"90","author":"RB Bhisitkul","year":"2006","unstructured":"Bhisitkul RB (2006) Vascular endothelial growth factor biology: clinical implications for ocular treatments. Br J Ophthalmol 90:1542\u20131547","journal-title":"Br J Ophthalmol"},{"key":"1970_CR3","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1001\/archopht.120.3.338","volume":"120","author":"MG Krzystolik","year":"2002","unstructured":"Krzystolik MG, Afshari MA, Adamis AP, Gaudreault J, Gragoudas ES, Michaud NA, Li W, Connolly E, O'Neill CA, Miller JW (2002) Prevention of experimental choroidal neovascularization with intravitreal anti-vascular endothelial growth factor antibody fragment. Arch Ophthalmol 120:338\u2013346","journal-title":"Arch Ophthalmol"},{"key":"1970_CR4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1350-9462(02)00043-5","volume":"22","author":"AN Witmer","year":"2003","unstructured":"Witmer AN, Vrensen GF, Van Noorden CJ, Schlingemann RO (2003) Vascular endothelial growth factors and angiogenesis in eye disease. Prog Retin Eye Res 22:1\u201329","journal-title":"Prog Retin Eye Res"},{"key":"1970_CR5","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1097\/01.iae.0000242842.14624.e7","volume":"26","author":"N Ferrara","year":"2006","unstructured":"Ferrara N, Damico L, Shams N, Lowman H, Kim R (2006) Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration. Retina 26:859\u2013870","journal-title":"Retina"},{"key":"1970_CR6","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.exer.2007.05.008","volume":"85","author":"J Lowe","year":"2007","unstructured":"Lowe J, Araujo J, Yang J, Reich M, Oldendorp A, Shiu V, Quarmby V, Lowman H, Lien S, Gaudreault J, Maia M (2007) Ranibizumab inhibits multiple forms of biologically active vascular endothelial growth factor in vitro and in vivo. Exp Eye Res 85:425\u2013430","journal-title":"Exp Eye Res"},{"key":"1970_CR7","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1056\/NEJMoa062655","volume":"355","author":"DM Brown","year":"2006","unstructured":"Brown DM, Kaiser PK, Michels M, Soubrane G, Heier JS, Kim RY, Sy JP, Schneider S, ANCHOR Study Group (2006) Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med 355:1432\u20131444","journal-title":"N Engl J Med"},{"key":"1970_CR8","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJMoa054481","volume":"355","author":"PJ Rosenfeld","year":"2006","unstructured":"Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, Kim RY, MARINA Study Group (2006) Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 355:1419\u20131431","journal-title":"N Engl J Med"},{"key":"1970_CR9","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ophtha.2008.10.018","volume":"116","author":"DM Brown","year":"2009","unstructured":"Brown DM, Michels M, Kaiser PK, Heier JS, Sy JP, Ianchulev T (2009) Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: two-year results of the ANCHOR study. Ophthalmology 116:57\u201365, e5","journal-title":"Ophthalmology"},{"key":"1970_CR10","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1755-3768.2009.01843.x","volume":"88","author":"Y Tano","year":"2010","unstructured":"Tano Y, Ohji M (2010) EXTEND-I: safety and efficacy of ranibizumab in Japanese patients with subfoveal choroidal neovascularization secondary to age-related macular degeneration. Acta Ophthalmol 88:309\u2013316","journal-title":"Acta Ophthalmol"},{"key":"1970_CR11","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ophtha.2003.05.011","volume":"111","author":"WM Hsu","year":"2004","unstructured":"Hsu WM, Cheng CY, Liu JH, Tsai SY, Chou P (2004) Prevalence and causes of visual impairment in an elderly Chinese population in Taiwan: the Shihpai Eye Study. Ophthalmology 111:62\u201369","journal-title":"Ophthalmology"},{"key":"1970_CR12","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1080\/09286586.2001.11644261","volume":"8","author":"JH Liu","year":"2001","unstructured":"Liu JH, Cheng CY, Chen SJ, Lee FL (2001) Visual impairment in a Taiwanese population: prevalence, causes, and socioeconomic factors. Ophthalmic Epidemiol 8:339\u2013350","journal-title":"Ophthalmic Epidemiol"},{"key":"1970_CR13","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1136\/bjo.87.4.469","volume":"87","author":"M Miyazaki","year":"2003","unstructured":"Miyazaki M, Nakamura H, Kubo M, Kiyohara Y, Oshima Y, Ishibashi T, Nose Y (2003) Risk factors for age related maculopathy in a Japanese population: the Hisayama Study. Br J Ophthalmol 87:469\u2013472","journal-title":"Br J Ophthalmol"},{"key":"1970_CR14","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1136\/bjo.2005.083733","volume":"90","author":"TY Wong","year":"2006","unstructured":"Wong TY, Loon SC, Saw SM (2006) The epidemiology of age related eye diseases in Asia. Br J Ophthalmol 90:506\u2013511","journal-title":"Br J Ophthalmol"},{"key":"1970_CR15","doi-asserted-by":"crossref","unstructured":"Lee FL, Kwon OW, Chung H, Lai CC, Sheu SJ, Yoon YH, EXTEND III Study Group (2012) Ranibizumab in South Korean and Taiwanese patients with age-related macular degeneration: primary outcome of the EXTEND III study. Acta Ophthalmol [Epub ahead of print]. doi: 10.1111\/j.1755-3768.2011.02262.x","DOI":"10.1111\/j.1755-3768.2011.02262.x"},{"key":"1970_CR16","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.ajo.2007.08.012","volume":"144","author":"PK Kaiser","year":"2007","unstructured":"Kaiser PK, Brown DM, Zhang K, Hudson HL, Holz FG, Shapiro H, Schneider S, Acharya NR (2007) Ranibizumab for predominantly classic neovascular age-related macular degeneration: subgroup analysis of first-year ANCHOR results. Am J Ophthalmol 144:850\u2013857","journal-title":"Am J Ophthalmol"},{"key":"1970_CR17","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0002-9394(03)00223-X","volume":"136","author":"KJ Blinder","year":"2003","unstructured":"Blinder KJ, Bradley S, Bressler NM, Bressler SB, Donati G, Hao Y, Ma C, Menchini U, Miller J, Potter MJ, Pournaras C, Reaves A, Rosenfeld PJ, Strong HA, Stur M, Su XY, Virgili G; Treatment of Age-related Macular Degeneration with Photodynamic Therapy study group; Verteporfin in Photodynamic Therapy study group (2003) Effect of lesion size, visual acuity, and lesion composition on visual acuity change with and without verteporfin therapy for choroidal neovascularization secondary to age-related macular degeneration: TAP and VIP report no. 1. Am J Ophthalmol 136:407\u2013418","journal-title":"Am J Ophthalmol"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-012-1970-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-012-1970-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-012-1970-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T19:48:16Z","timestamp":1559072896000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-012-1970-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,2]]},"references-count":17,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["1970"],"URL":"https:\/\/doi.org\/10.1007\/s00417-012-1970-3","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,2]]}}}